Page last updated: 2024-08-23

bisantrene and Ovarian Neoplasms

bisantrene has been researched along with Ovarian Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Copeland, LJ; Gershenson, DM; Kavanagh, JJ; Saul, PB1
Alberts, DS; Boutselis, JG; Cowan, JD; Neilan, BA; Surwit, EA1

Other Studies

2 other study(ies) available for bisantrene and Ovarian Neoplasms

ArticleYear
A phase II trial of bisantrene (CL216,942) in refractory epithelial ovarian cancer.
    Gynecologic oncology, 1986, Volume: 23, Issue:1

    Topics: Adult; Aged; Anthracenes; Carcinoma; Drug Evaluation; Female; Humans; Middle Aged; Ovarian Neoplasms

1986
Phase II trial of bisantrene in previously treated patients with ovarian carcinoma: a Southwest Oncology Group Study.
    Cancer treatment reports, 1986, Volume: 70, Issue:3

    Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Carcinoma; Drug Evaluation; Female; Humans; Middle Aged; Ovarian Neoplasms

1986